- Home
- ETON vs RRBI Comparison
ETON vs RRBI Comparison
Compare ETON & RRBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- RRBI
- Stock Information
- Founded
- ETON 2017
- RRBI 1998
- Country
- ETON United States
- RRBI United States
- Employees
- ETON N/A
- RRBI N/A
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- RRBI Hotels/Resorts
- Sector
- ETON Health Care
- RRBI Consumer Discretionary
- Exchange
- ETON Nasdaq
- RRBI Nasdaq
- Market Cap
- ETON 388.3M
- RRBI 406.6M
- IPO Year
- ETON 2018
- RRBI 2019
- Fundamental
- Price
- ETON $21.45
- RRBI $65.68
- Analyst Decision
- ETON Strong Buy
- RRBI Buy
- Analyst Count
- ETON 3
- RRBI 1
- Target Price
- ETON $29.67
- RRBI $67.00
- AVG Volume (30 Days)
- ETON 343.9K
- RRBI 14.7K
- Earning Date
- ETON 11-11-2025
- RRBI 10-29-2025
- Dividend Yield
- ETON N/A
- RRBI 0.92%
- EPS Growth
- ETON N/A
- RRBI 23.60
- EPS
- ETON N/A
- RRBI 5.67
- Revenue
- ETON $58,181,000.00
- RRBI $115,623,000.00
- Revenue This Year
- ETON $105.25
- RRBI $6.88
- Revenue Next Year
- ETON $40.84
- RRBI $7.01
- P/E Ratio
- ETON N/A
- RRBI $11.53
- Revenue Growth
- ETON 85.40
- RRBI 10.19
- 52 Week Low
- ETON $6.37
- RRBI $46.33
- 52 Week High
- ETON $23.00
- RRBI $68.20
- Technical
- Relative Strength Index (RSI)
- ETON 66.33
- RRBI 55.08
- Support Level
- ETON $19.48
- RRBI $62.87
- Resistance Level
- ETON $23.00
- RRBI $67.02
- Average True Range (ATR)
- ETON 1.15
- RRBI 1.43
- MACD
- ETON 0.04
- RRBI -0.25
- Stochastic Oscillator
- ETON 70.50
- RRBI 52.68
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About RRBI Red River Bancshares Inc.
Red River Bancshares Inc is the bank holding company for the red river bank. The principal business of the Bank is lending and accepting deposits from businesses, professionals, individuals, and public entities. The bank's primary deposit products are demand deposits, savings deposits, and time deposits. The bank maintains a diversified loan portfolio with a focus on commercial real estate (Owner Occupied and Non-Owner Occupied), one-to-four-family residential, commercial, and industrial loans, construction and development Loans, and others. also, provides Treasury Management Services, Private Banking Services, Brokerage Services, and Other Banking Services.